🔴 Icecure Medical is trading 6% down today after wider-than-expected Q2 losses

Icecure Medical is trading 6.03% down at $2.65 as U.S. stocks decline broadly, with sentiment pressured by last week’s Q2 revenue miss and wider-than-expected losses.

• Nasdaq is down 1.38% and the S&P 500 is down 0.65%.
• First-half revenue grew 45% despite the Q2 results.
• Positive breast-cancer study news from August 17 has not offset the broader risk-off mood.